A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for treating alcohol use disorder.
The data, published in JAMA Psychiatry, add to the growing body of evidence supporting the use of GLP-1 receptor agonists for ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
A new study suggests that semaglutide, a drug commonly used for diabetes and obesity, may also help reduce alcohol consumption.
As well as shedding pounds and controlling diabetes, Ozempic and Wegovy can help you drink less, researchers suggest ...